Literature DB >> 10799464

Comparison of commercial latex agglutination and sandwich enzyme immunoassays with a competitive binding inhibition enzyme immunoassay for detection of antigenemia and antigenuria in a rabbit model of invasive aspergillosis.

S F Hurst1, G H Reyes, D W McLaughlin, E Reiss, C J Morrison.   

Abstract

A commercial latex agglutination assay (LA) and a sandwich enzyme immunoassay (SEIA) (Sanofi Diagnostics Pasteur, Marnes-la-Coquette, France) were compared with a competitive binding inhibition assay (enzyme immunoassay [EIA]) to determine the potential uses and limitations of these antigen detection tests for the sensitive, specific, and rapid diagnosis of invasive aspergillosis (IA). Toward this end, well-characterized serum and urine specimens were obtained by using a rabbit model of IA. Serially collected serum or urine specimens were obtained daily from control rabbits or from rabbits immunosuppressed and infected systemically with Aspergillus fumigatus. By 4 days after infection, EIA, LA, and SEIA detected antigen in the sera of 93, 93, and 100% of A. fumigatus-infected rabbits, respectively, whereas antigen was detected in the urine of 93, 100, and 100% of the rabbits, respectively. False-positive results for non-A. fumigatus-infected rabbits for EIA, LA, and SEIA were as follows: for serum, 14, 11, and 23%, respectively; for urine, 14, 84, and 90%, respectively. Therefore, although the sensitivities of all three tests were similar, the specificity was generally greater for EIA than for LA or SEIA. Infection was also detected earlier by EIA, by which the serum of 53% of A. fumigatus-infected rabbits was positive as early as 1 day after infection, whereas the serum of only 27% of the rabbits tested by LA was positive. Although the serum of 92% of A. fumigatus-infected rabbits was positive by SEIA as early as 1 day after infection, the serum of a high percentage (50%) was false positive before infection. The urine of 21% of A. fumigatus-infected rabbits was positive by EIA as early as 1 day after infection, and the urine of none of the rabbits was false positive before infection. When EIA results for urine specimens were combined with those for serum, sensitivity was improved (i.e., 67% of rabbits were positive by 1 day after infection and only one rabbit gave a false-positive result). A total of 93% of A. fumigatus-infected rabbits were positive for antigen in urine as early as 1 day after infection and the urine of 100% of the rabbits was positive by SEIA. However, before infection, 79% of A. fumigatus-infected rabbits were false positive for antigen in urine by LA and 90% were false positive for antigen in urine by SEIA. These data indicate that the EIA has the potential to be used to diagnose IA with both serum and urine specimens and to detect a greater number of infections earlier with greater specificity than the specificities achieved with the commercial tests.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799464      PMCID: PMC95897          DOI: 10.1128/CDLI.7.3.477-485.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  40 in total

Review 1.  Current trends in the detection of antigenaemia, metabolites and cell wall markers for the diagnosis and therapeutic monitoring of fungal infections.

Authors:  P E Verweij; D Poulain; T Obayashi; T F Patterson; D W Denning; J Ponton
Journal:  Med Mycol       Date:  1998       Impact factor: 4.076

Review 2.  Tools and trends in the detection of Aspergillus fumigatus.

Authors:  J P Latgé
Journal:  Curr Top Med Mycol       Date:  1995

3.  Evaluation of eight antibody tests and one antigen test for the diagnosis of invasive aspergillosis.

Authors:  R Kappe; A Schulze-Berge; H G Sonntag
Journal:  Mycoses       Date:  1996 Jan-Feb       Impact factor: 4.377

4.  Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis.

Authors:  P E Verweij; A J Rijs; B E De Pauw; A M Horrevorts; J A Hoogkamp-Korstanje; J F Meis
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

5.  Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients.

Authors:  P E Verweij; D Stynen; A J Rijs; B E de Pauw; J A Hoogkamp-Korstanje; J F Meis
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

6.  Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis.

Authors:  A Sulahian; M Tabouret; P Ribaud; J Sarfati; E Gluckman; J P Latgé; F Derouin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

7.  Aspergillus antigen detection in the diagnosis of invasive aspergillosis.

Authors:  T F Patterson; P Miniter; J E Patterson; J M Rappeport; V T Andriole
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

8.  Pulmonary aspergillosis: early diagnosis improves survival.

Authors:  M von Eiff; N Roos; R Schulten; M Hesse; M Zühlsdorf; J van de Loo
Journal:  Respiration       Date:  1995       Impact factor: 3.580

9.  Use of the Pastorex aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis.

Authors:  V Hopwood; E M Johnson; J M Cornish; A B Foot; E G Evans; D W Warnock
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411

10.  Antigens of Aspergillus fumigatus produced in vivo.

Authors:  J Sarfati; D G Boucias; J P Latgé
Journal:  J Med Vet Mycol       Date:  1995 Jan-Feb
View more
  6 in total

1.  Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis.

Authors:  Claudine Pinel; Hélène Fricker-Hidalgo; Bernadette Lebeau; Frédéric Garban; Rébecca Hamidfar; Pierre Ambroise-Thomas; Renée Grillot
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Well-characterized monoclonal antibodies against cell wall antigen of Aspergillus species improve immunoassay specificity and sensitivity.

Authors:  Wei Hao; Yu-Xian Pan; Yan-Qing Ding; Sha Xiao; Kai Yin; Ya-Di Wang; Li-Wen Qiu; Qing-Lin Zhang; Patrick C Y Woo; Susanna K P Lau; Kwok-Yung Yuen; Xiao-Yan Che
Journal:  Clin Vaccine Immunol       Date:  2007-11-21

3.  Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole.

Authors:  T Wu; K Wright; S F Hurst; C J Morrison
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

4.  Rapid differentiation of Aspergillus species from other medically important opportunistic molds and yeasts by PCR-enzyme immunoassay.

Authors:  Liliana de Aguirre; Steven F Hurst; Jong Soo Choi; Jong Hee Shin; Hans Peter Hinrikson; Christine J Morrison
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

5.  Competitive binding inhibition enzyme-linked immunosorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasis.

Authors:  Christine J Morrison; Steven F Hurst; Errol Reiss
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 6.  Animal models: an important tool in mycology.

Authors:  Javier Capilla; Karl V Clemons; David A Stevens
Journal:  Med Mycol       Date:  2007-12       Impact factor: 4.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.